William Ure Primrose

Gyreox Ltd. engages in research and experimental development on biotechnology. The company was founded on May 20, 2019 and is headquartered in Oxford, the United Kingdom.

CYP Design Ltd. provides drug research and development services. It engages in the supporting drug research and development needs by offering stabilized, highly active cytochrome P450 (CYP) enzyme products. The firm also offers reliable contract research services in metabolism and toxicity testing and in bio catalysis. It has developed a generic expression system for the production of recombinant cytochrome P450 (CYP) in yeast, insect and mammalian cells. The company was founded by Bhabatosh Chaudhuri, Paul Barton Rodgers and William Primose in 2012 and is headquartered in Leicester, the United Kingdom.

PanTherix Ltd. is a privately held anti-infectives company using structure-based drug design to discover and develop new antibiotics acting on novel targets. The company integrates structural and functional information obtained by protein crystallography and enzymology to accelerate the gene to drug process. The company was founded in 1997 and is headquartered in Glasgow, the United Kingdom.

Theryte Ltd. operated as a drug discovery and development company that is committed to bringing new cancer treatments to market. It also operated a virtual model for its discovery and development operations, outsourcing its chemistry, discovery biology and in vivo testing to a number of specialist commercial providers in Europe and North America. The company was founded by Hilmar Meek Warenius, Guenter Herbert Schmidt, Robert John Bishop and Robert Alexander Walker Johnstone on November 20, 1997 and headquartered in Keynsham, the United Kingdom.